Dr. Susan Love’s Menopause and Hormone Book

Menopause is not a disease that needs to be cured

Dr. Susan Love's Menopause and Hormone Book, by @DrSusanLove, on Flickr
Making Informed Choices

In the first edition of this important bestselling book, praised by Newsday as “the bible for a whole generation of menopausal women”, renowned physician and pioneering women’s health advocate Dr. Susan Love warned about the potential dangers of the long-term prescription of hormone replacement therapy. Her insightful words of caution have been backed up by the stunning results of the recent studies on hormone replacement.

In the revised edition, Dr. Love offers a remarkably clear set of guidelines as to what the studies have shown about the risks regarding:

  • heart disease
  • breast cancer
  • stroke
  • other conditions
  • what effect hormone therapy has on osteoporosis.

She offers definitive expert advice about:

  • whether or not to go on hormone replacement therapy and, if so, for how long
  • as well as how to taper off hormones
  • and she introduces the alternative methods for treating the symptoms of menopause.

Dr. Love stresses that menopause is not a disease that needs to be cured—it is a natural life stage, and every woman ought to choose her own mix of options for coping with symptoms. A questionnaire about your own health history and life preferences helps you develop a program that will best fit your unique needs. With clarity and compassion, she walks you through every option for both the short and the long term, including:

  • lifestyle changes (diet, exercise, and stress management)
  • alternative therapies (including herbs and homeopathic remedies)
  • available medications other than hormones

Book reviews – More about Estrogens – HRTWomen’s Health
Visit Dr. Susan Love website, on Facebook and Twitter

On Flickr®

68 Médicaments à éviter: plus dangereux qu’utiles et commercialisés en France en 2014

Pour mieux soigner : des médicaments à écarter, 2014

Pour mieux soigner : des médicaments à écarter - Actualisation 2014
Pour mieux soigner : des médicaments à écarter – Actualisation 2014

La revue médicale Prescrire a remis à jour sa liste des médicaments plus dangereux qu’utiles qui devraient être écartés dans l’intérêt des patients.

Se fondant sur des études réalisées entre 2010 et 2013, Prescrire liste 68 médicaments dont la balance bénéfices-risques est défavorable dans toutes les situations cliniques pour lesquelles ils sont autorisés.

Cancérologie:

catumaxomab, panitumumab, trabectédine, vandétanib, vinflunine

Cardiologie:

aliskirène, fénofibrate, bézafibrate, ciprofibrate, ivabradine, nicorandil, trimétazidine

Dermatologie – Allergologie:

tacrolimus, méquitazine, prométhazine

Diabétologie – Nutrition:

linagliptine, saxagliptine, sitagliptine, vildagliptine, orlistat

Douleur:

célécoxib, étoricoxib, parécoxib, floctafénine, kétoprofène, piroxicam, dénosumab, strontium, ranélate, diacéréine, glucosamine

Rhumatologie:

méthocarbamol, quinine, colchimax, percutalgine, cortisal

Gastro-entérologie:

dompéridone, prucalopride

Gynécologie – Endocrinologie:

tibolone

Hématologie:

fer dextran

Infectiologie:

moxifloxacine, télithromycine

Neurologie:

donépézil, galantamine, rivastigmine, mémantine, flunarizine, tolcapone

Pneumologie – ORL:

éphédrine, naphazoline, oxymétazoline, pseudoéphédrine, tuaminoheptane, omalizumab, pholcodine, pirfénidone, tixocortol

Psychiatrie – Dépendances:

agomélatine, duloxétine, milnacipran, venlafaxine, ianeptine, asénapine, dapoxétine, étifoxine, bupropione, varénicline

Sources:

Revues de Presse:

Articles similaires:

Our Job is to Keep Moving Forward. It’s Not to make everybody approve of our Journey

Art Jonak: Innovator ☈ Simplifier☍ Speaker☄ Thought Leader☼ Master #140CharacterConversationCreator✍ Optimist☮♥ Entrepreneur☂ Problem Solver♔ Imitated, never duplicated✩

Art Jonak, Founder MLM Mastermind Event☍ Speaker☄ Thought Leader☼ Globe Trotter✈ (79 countries) Optimist☮ http://Facebook.com/ArtJonak ♥ Entrepreneur☂ Imitated, never duplicated
Our job is to keep moving forward. It’s not to make everybody approve of our journey.
by @ArtJonak

Art Jonak Daily MotivationFacebookTwitterWebsite – our Quotes

Enquête sur Trois Générations Distilbène

Le Parisien du mercredi 28 août 2013

Enquête sur Trois Générations Distilbène, sur Flickr
Le Parisien du mercredi 28 août 2013

sources

Sur Flickr®

Le Distilbène DES, en savoir plus

We may have more to worry about Bisphenol-A than once thought

BPA is still everywhere, and mounting evidence suggests harmful effects

BPA is still everywhere, and mounting evidence suggests harmful effects
Thermal paper contains Bisphenols

Despite many BPA-free products, Bisphenol-A can still be found in many common items such as medical devices, dental sealants and compact discs, to name a few. Even paper receipts from the grocery store and cash machines often contain BPA.

In short, it’s pretty hard to avoid the chemical…

Read BPA is still everywhere, and mounting evidence suggests harmful effects, by Amanda Mascarelli, 10 Dec 2013.

Our posts about BPA – Endocrine Disruptors – Pesticides – Phthalates.

Pathological Semen and Anatomical Abnormalities of the Genital Tract in DES-Exposed Males

In utero exposure to Diethylstilbestrol is associated with terrible side-effects in DES Sons

Abstract:

Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero.
In utero exposure to Diethylstilbestrol is associated with terrible side-effects in DES Sons.

The in utero effects of diethylstilbestrol on the human male genital tract are reported in our followup study of male offspring of mothers treated with diethylstilbestrol. Anatomical and functional abnormalities were significantly greater in male patients exposed to diethylstilbestrol compared to male controls whose mothers were all participants in a prospective, randomized double-blind study on the effects of diethylstilbestrol on pregnancy at our hospital during the early 1950s. Epididymal cysts, hypotrophic testes and capsular induration of the testes were among the more common genital lesions found in more than 25 per cent of 159 male patients exposed to diethylstilbestrol compared to a 6.8 per cent incidence in 161 male controls. Spermatozoal analysis revealed severe pathological changes (Eliasson score more than 10) in 32 per cent of 31 patients exposed to diethylstilbestrol and 0 per cent of 20 male controls. Abnormal findings on physical examination combined with severe sperm abnormalities (Eliasson score more than 10) were found in 23 per cent of the male patients exposed to diethylstilbestrol versus none of the male controls. Cytologic examinations revealed no malignant cells from urine samples before and after prostatic massage or ejaculation, prostatic fluids and aspirates from epididymal cysts.

Sources: NCBI, J Urol. 1977 Apr;117(4):477-80., PMID: 850321, Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero.

Related posts:

More DES DiEthylStilbestrol Resources

Patient: Doctor, I don’t feel well and I’m not sure why

Probably what doctors would prescribe more often if not pressured by pharmaceutical companies …

Patient: Doctor, I don't feel well and I'm not sure why, #comics on Flickr
Probably what doctors would prescribe more often if not pressured by pharmaceutical companies …

Probably what doctors would prescribe more often if not pressured by pharmaceutical companies …

On Flickr®

Watch the Diaporama, and the Art photo set on  DES Diethylstilbestrol's photostream on Flickr

If you already have a flickr® account, add us as a contact
Email your photos to des.daughter@gmail.com with a short description and title :-)

See more Comics – about Doctors and Medical Representatives
Our posts about prescriptions drugs – the FDA and the Pharmaceutical Industry

Women’s Reproductive Health Concerns and UnKnowns

Many women are still unaware of fertility issues

The science of baby-making still a mystery for many women
The science of baby-making still a mystery for many women.

A new study by Yale School of Medicine researchers – published in the last issue of Fertility and Sterility – provides insight into how much women of reproductive age in the United States know about reproductive health.

Some of women’s biggest questions about fertility and reproduction:

  • Does having sex more than once a day increase chances of conception?
  • Will specific sexual positions or elevating the pelvis after intercourse make you more likely to become pregnant?
  • Does intercourse need to occur before or after ovulation to optimize conception?
  • Do women keep producing eggs throughout their reproductive years?

Among the findings were:

  • 50% of reproductive-age women had never discussed their reproductive health with a medical provider.
  • 30% of the women reported that they only visited a reproductive health provider less than once a year or not at all.
  • 40% were concerned about their ability to conceive.
  • 50% did not know that multivitamins and folic acid were prescribed to prevent birth defects.
  • More than 25% did not know about the negative effects of sexually transmitted diseases, obesity, smoking or irregular periods.
  • 20% did not know that aging can impact fertility and increase rates of miscarriage.
  • 50% of the women thought that having sex multiple times in a day increased their likelihood of getting pregnant.
  • Over 33% of women thought that different sex positions can increase their odds of getting pregnant.
  • 10% did not know that they should have sex before ovulation to increase the chances of getting pregnant instead of after ovulation.

Press Articles

Sadly for many DES daughters having their own children is not possible! Many of us who have experienced miscarriages, want to have kids but are struggling or unable to…

Institutional Corruption and the Pharmaceutical Industry

Certain practices have corrupted medical research, the practice of medicine and drug safety

Introduction:

Today, the goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption — that is, widespread or systemic practices, usually legal, that undermine an institution’s objectives or integrity. We will see that the pharmaceutical industry’s own purposes are often undermined. In addition, pharmaceutical industry funding of election campaigns and lobbying skews the legislative process that sets pharmaceutical policy. Moreover, certain practices have corrupted medical research, the production of medical knowledge, the practice of medicine, drug safety, and the Food and Drug Administration’s oversight of pharmaceutical marketing. As a result, practitioners may think they are using reliable information to engage in sound medical practice while actually relying on misleading information and therefore prescribe drugs that are unnecessary or harmful to patients, or more costly than equivalent medications. At the same time, patients and the public may believe that patient advocacy organizations effectively represent their interests while these organizations actually neglect their interests.

Harvard University Articles:

JLME Issue on Institutional Corruption and the Pharmaceutical Industry
Today, the goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption — that is, widespread or systemic practices, usually legal, that undermine an institution’s objectives or integrity.

The Edmond J. Safra Center put together 16 articles that investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs and what is corrupted. The articles address five topics:

  1. systemic problems,
  2. medical research,
  3. medical knowledge and practice,
  4. marketing,
  5. and patient advocacy organizations.

Sources:

Not Just a Pretty Face

The Ugly Side of the Beauty Industry

Not Just a Pretty Face on Flickr
Not Just a Pretty Face – by Stacy Malkan – chronicles the quest that led a group of health and environmental activists to the world’s largest cosmetics companies to ask some tough questions.

by Stacy Malkan

  • Lead in lipstick?
  • 1,4 dioxane in baby soap?
  • Coal tar in shampoo?
  • How is this possible?

Simple. The $35 billion cosmetics industry is so powerful that they have kept themselves unregulated for decades.

  • Why do companies market themselves as pink ribbon leaders in the fight against breast cancer, yet use hormone-disrupting and carcinogenic chemicals that may contribute to that very disease?
  • Why do products used by men and women of childbearing age contain chemicals linked to birth defects and infertility?

As doors slammed in their faces and the beauty myth peeled away, the industry’s toxic secrets began to emerge. This scathing investigation peels away less-than-lovely layers to expose an industry in dire need of an extreme makeover. The good news is that while the major multinational companies fight for their right to use hazardous chemicals, entrepreneurs are developing safer non-toxic technologies and building businesses on the values of health, justice and personal empowerment.

All our posts about BPA – Cancer – Endocrine Disruptors – Phthalates.

On Flickr®